Like so many others, I have migrated to the other platform. Same profile name. Come and join us. I will slowly drop off from here. See you on the other side where the sky is blue.
Charles de Bock
@charles_debock
No longer active on this platform. Please see me at alternative where sky is blue. Same handle.
466 Following 645 Followers 955 Posts
Latest posts 5
Following our publication on T-ALL this week, pleased to share another paper from our group now published in @NatureComms linking PU.1 to glucocorticoid sensitivity in B-ALL rdcu.be/dZB01 which was a massive team effort @KidsCancerInst ; 🧵n/8 below
Developing targeted therapies for children diagnosed with T-ALL and especially those who relapse are essential to improve outcomes. I am pleased to share our work, now published @BloodCancerJnl that describes a new AKR1C3 activated prodrug: Thread👇🧵rdcu.be/dZh70
This was a great chance to discuss some of the key highlights from the @EHA_Hematology conference in Madrid. Tune in for more podcasts from @Hemasphere_EHA as we round out 2024 and head into 2025.
🎧New HemaSphere Podcast Episode!View quoted post on X
In the latest episode, Dr Charles de Bock talks with Prof H. Josef Vormoor and Dr Maria Ester Bernardo, Chair and Co-Chair of EHA’s Pediatric Hematology Specialized Working Group. They discuss highlights from the EHA 2024 Congress in Madrid, including key lectures, new insights and what they could mean for clinicians, researchers, patients and their families, along with hopes and expectations for the EHA2025 Congress in Milan.
“Best of Pediatric Hematology from EHA2024”, is on our website hemasphere-podcast.captivate.fm , all major podcast platforms (Spotify, Apple Podcast, and more), and our YouTube channel. Listen and enjoy casual, insightful discussions about #hematology research.
We are pleased to offer HemaSphere’s full listing of publications about pediatric hematology, now in a dedicated collection. This online collection will be added to monthly 👉 bit.ly/4eQmptj
This is a great opportunity to join a fantastic group! Check out the link below.
🚀🚀🚀 Exciting opportunity! We are hiring a post-doc researcher to work on targeted therapies for T-cell ALL...if you are passionate about innovative treatments, apply now! Please spread the word 🥳🥳🥳View quoted post on X
tuni.rekrytointi.com/paikat/?o=A_RJ…